<div id="readability-page-1"><p>Morgan Stanley analyst Thibault Boutherin maintained a Hold rating on Merck KGaA today and set a price target of €135.00.</p><h3>TipRanks Cyber Monday Sale</h3><ul><li> Claim 60% off TipRanks Premium  for data-backed insights and research tools you need to invest with confidence.  </li><li>  Subscribe to TipRanks' Smart Investor Picks  and see our data in action through our high-performing model portfolio - <u> now also 60% off </u></li></ul> <p>Boutherin covers the Healthcare sector, focusing on stocks such as Novartis AG, Novo Nordisk, and Merck KGaA. According to TipRanks, Boutherin has an average return of <span>3.9%</span> and a 49.06% success rate on recommended stocks. </p> <p>In a report released on November 17, Bernstein also maintained a Hold rating on the stock with a €135.00 price target.</p></div>

<p>Morgan Stanley analyst Thibault Boutherin maintained a Hold rating on Merck KGaA with a price target of €135.00. Boutherin, who covers the Healthcare sector, has an average return of 3.9% and a 49.06% success rate. Bernstein also maintained a Hold rating with the same price target on November 17.</p>

Morgan Stanley Remains a Hold on Merck KGaA (0O14)